1548.HK

Genscript Biotech Corporation [1548.HK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

1548.HK Stock Summary

Top 10 Correlated ETFs

1548.HK


Top 10 Correlated Stocks

1548.HK


In the News

1548.HK Financial details

Company Rating
Neutral
Market Cap
30.95B
Income
-592.33M
Revenue
1.28B
Book val./share
0.64
Cash/share
0.9
Dividend
-
Dividend %
-
Employees
6.94K
Optionable
No
Shortable
Yes
Earnings
10 Mar 2024
P/E
-11.1
Forward P/E
-
PEG
-1.91
P/S
7.6
P/B
4.7
P/C
16.11
P/FCF
-14.69
Quick Ratio
2.68
Current Ratio
3.23
Debt / Equity
0.6
LT Debt / Equity
0.37
-
-
EPS (TTM)
-0.28
EPS next Y
0
EPS next Q
-
EPS this Y
-38.89%
EPS next Y
-101.05%
EPS next 5Y
-107.28%
EPS last 5Y
NAN%
Revenue last 5Y
22.05%
Revenue Q/Q
21.9%
EPS Q/Q
-2.42%
-
-
-
-
SMA20
-
SMA50
-16.67%
SMA100
-31.82%
Inst Own
-
Inst Trans
-
ROA
-17%
ROE
-45%
ROC
-0.22%
Gross Margin
49%
Oper. Margin
-70%
Profit Margin
-68%
Payout
-
Shs Outstand
2.11B
Shs Float
1.07B
-
-
-
-
Target Price
-
52W Range
12.56-24.95
52W High
-39.58%
52W Low
+20.83%
RSI
46
Rel Volume
0.81
Avg Volume
11.93M
Volume
9.62M
Perf Week
-6.57%
Perf Month
6.93%
Perf Quarter
-28.57%
Perf Half Y
-25.49%
-
-
-
-
Beta
1.089
-
-
Volatility
0.19%, 0.88%
Prev Close
0%
Price
14.5
Change
2.84%

1548.HK Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.130.150.210.240.3
Net income per share
0.01-0.05-0.11-0.18-0.11
Operating cash flow per share
0.17-0.02-0.08-0.07-0.06
Free cash flow per share
0.13-0.08-0.14-0.13-0.16
Cash per share
0.320.220.40.690.6
Book value per share
0.270.210.470.520.48
Tangible book value per share
0.260.180.410.660.64
Share holders equity per share
0.270.210.470.520.48
Interest debt per share
00.010.030.190.3
Market cap
2.42B4.21B2.75B8.98B6.67B
Enterprise value
1.93B3.98B2.18B7.96B6B
P/E ratio
113.88-43.42-13.44-25.04-29.42
Price to sales ratio
10.4615.397.0518.3310.67
POCF ratio
7.85-140.48-18.23-65.66-55.48
PFCF ratio
10.2-29.99-10.09-33.29-19.84
P/B Ratio
5.0510.993.068.596.6
PTB ratio
5.0510.993.068.596.6
EV to sales
8.3614.565.5816.249.59
Enterprise value over EBITDA
110.75-35.42-12.48-23.3-15.42
EV to operating cash flow
6.28-132.86-14.43-58.18-49.88
EV to free cash flow
8.16-28.36-7.99-29.49-17.84
Earnings yield
0.01-0.02-0.07-0.04-0.03
Free cash flow yield
0.1-0.03-0.1-0.03-0.05
Debt to equity
0.010.050.050.370.61
Debt to assets
0.010.020.030.170.24
Net debt to EBITDA
-27.752.033.2931.73
Current ratio
4.432.473.033.973.23
Interest coverage
98.27-168.18-144.25-159.5-33.02
Income quality
14.50.310.740.380.53
Dividend Yield
00.010.1500
Payout ratio
0-0.25-2.0500
Sales general and administrative to revenue
0.180.20.230.270.29
Research and developement to revenue
0.320.680.670.730.62
Intangibles to total assets
0.040.050.030.020.01
Capex to operating cash flow
-0.233.680.810.971.8
Capex to revenue
-0.31-0.4-0.31-0.27-0.35
Capex to depreciation
-5.74-5.42-3.77-2.9-3.53
Stock based compensation to revenue
0.040.040.050.080.1
Graham number
0.270.491.071.431.08
ROIC
0.01-0.33-0.21-0.26-0.26
Return on tangible assets
0.02-0.11-0.15-0.16-0.09
Graham Net
0.11-0.030.140.340.08
Working capital
525.95M329.54M665.26M1.23B1.22B
Tangible asset value
458.37M331.57M775.46M1.35B1.34B
Net current asset value
255.79M36.93M361.36M792.89M581.24M
Invested capital
0.010.050.050.370.61
Average receivables
161.6M70.46M107.41M142.09M123.36M
Average payables
9.67M14.41M20.5M26.78M42.97M
Average inventory
9.65M14.46M24.12M38.05M52.15M
Days sales outstanding
107.1997.56132.37106.0860.83
Days payables outstanding
56.3469.1363.2253.0663.28
Days of inventory on hand
62.5964.6685.867868.02
Receivables turnover
3.413.742.763.446
Payables turnover
6.485.285.776.885.77
Inventory turnover
5.835.654.254.685.37
ROE
0.04-0.25-0.23-0.34-0.22
Capex per share
-0.04-0.06-0.06-0.07-0.1

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2021-06-302021-12-312022-06-302022-12-31 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.120.130.150.150.19
Net income per share
-0.05-0.13-0.06-0.05-0.04
Operating cash flow per share
-0.02-0.05-0.03-0.03-0.09
Free cash flow per share
-0.05-0.08-0.07-0.09-0.13
Cash per share
0.610.670.590.60.9
Book value per share
0.510.50.360.480.64
Tangible book value per share
0.570.650.410.640.98
Share holders equity per share
0.510.50.360.480.64
Interest debt per share
0.020.190.230.290.39
Market cap
8.62B9.22B7.58B6.7B4.73B
Enterprise value
7.72B8.19B7.03B6.02B3.71B
P/E ratio
-23.66-8.61-13.98-17.5-12.64
Price to sales ratio
37.5635.3824.4820.8612.09
POCF ratio
-240.48-91.32-122.24-114.86-25.27
PFCF ratio
-82.42-55.79-55.75-34.64-17.69
P/B Ratio
8.538.8110.016.633.49
PTB ratio
8.538.8110.016.633.49
EV to sales
33.6331.4522.6918.769.49
Enterprise value over EBITDA
-58.43-39.12-45.99-24.57-19.12
EV to operating cash flow
-215.32-81.17-113.32-103.3-19.84
EV to free cash flow
-73.8-49.59-51.69-31.15-13.89
Earnings yield
-0.01-0.03-0.02-0.01-0.02
Free cash flow yield
-0.01-0.02-0.02-0.03-0.06
Debt to equity
0.040.370.630.610.6
Debt to assets
0.020.170.220.240.24
Net debt to EBITDA
6.834.893.622.755.23
Current ratio
3.263.972.923.235.64
Interest coverage
00000
Income quality
0.390.380.460.612
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.250.30.260.320.27
Research and developement to revenue
0.760.70.570.660.53
Intangibles to total assets
0.020.020.020.010.01
Capex to operating cash flow
1.920.641.192.320.43
Capex to revenue
-0.3-0.25-0.24-0.42-0.2
Capex to depreciation
-2.99-2.81-2.46-4.31-2.26
Stock based compensation to revenue
0.060.10.120.090.1
Graham number
0.731.20.730.70.8
ROIC
-0.15-0.16-0.14-0.17-0.1
Return on tangible assets
-0.05-0.12-0.06-0.04-0.03
Graham Net
0.280.330.040.080.34
Working capital
950.05M1.23B984.98M1.22B2.03B
Tangible asset value
1.12B1.35B848.82M1.34B2.06B
Net current asset value
642.63M792.89M241.88M581.24M1.17B
Invested capital
0.040.370.630.610.6
Average receivables
117.19M117.54M122.39M103.31M118.39M
Average payables
25.31M28.71M31.52M44.31M48.04M
Average inventory
33.32M39.62M47.13M54.92M55.73M
Days sales outstanding
36.3249.2129.7529.2330.48
Days payables outstanding
26.9623.2920.9726.0716.78
Days of inventory on hand
34.5234.2331.8328.0321.44
Receivables turnover
2.481.833.033.082.95
Payables turnover
3.343.864.293.455.36
Inventory turnover
2.612.632.833.214.2
ROE
-0.09-0.26-0.18-0.09-0.07
Capex per share
-0.03-0.03-0.04-0.06-0.04

1548.HK Frequently Asked Questions

What is Genscript Biotech Corporation stock symbol ?

Genscript Biotech Corporation is a CN stock and trading under the symbol 1548.HK

What is Genscript Biotech Corporation stock quote today ?

Genscript Biotech Corporation stock price is $14.5 today.

Is Genscript Biotech Corporation stock public?

Yes, Genscript Biotech Corporation is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap